| Sedentary behavior, exercise, and cardiovascular health CJ Lavie, C Ozemek, S Carbone, PT Katzmarzyk, SN Blair Circulation research 124 (5), 799-815, 2019 | 1395 | 2019 |
| An overview and update on obesity and the obesity paradox in cardiovascular diseases A Elagizi, S Kachur, CJ Lavie, S Carbone, A Pandey, FB Ortega, ... Progress in cardiovascular diseases 61 (2), 142-150, 2018 | 659 | 2018 |
| Obesity paradox in cardiovascular disease: where do we stand? S Carbone, JM Canada, HE Billingsley, MS Siddiqui, A Elagizi, CJ Lavie Vascular Health and Risk Management 15, 89-100, 2019 | 415 | 2019 |
| Exercise Intolerance in Patients With Heart Failure: JACC State-of-the-Art Review MG Del Buono, R Arena, BA Borlaug, S Carbone, JM Canada, ... Journal of the American College of Cardiology 73 (17), 2209-2225, 2019 | 319* | 2019 |
| Obesity, risk of diabetes and role of physical activity, exercise training and cardiorespiratory fitness S Carbone, MG Del Buono, C Ozemek, CJ Lavie Progress in cardiovascular diseases 62 (4), 327-333, 2019 | 306 | 2019 |
| Coronary Microvascular Dysfunction Across the Spectrum of Cardiovascular Diseases: JACC State-of-the-Art Review MG Del Buono, RA Montone, M Camilli, S Carbone, J Narula, CJ Lavie, ... Journal of the American College of Cardiology 78 (13), 1352-1371, 2021 | 288 | 2021 |
| Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin … O Vaccaro, M Masulli, A Nicolucci, E Bonora, S Del Prato, AP Maggioni, ... The lancet Diabetes & endocrinology 5 (11), 887-897, 2017 | 276 | 2017 |
| Obesity and heart failure: focus on the obesity paradox S Carbone, CJ Lavie, R Arena Mayo Clinic Proceedings 92 (2), 266-279, 2017 | 275 | 2017 |
| Inhibition of the NLRP3 inflammasome limits the inflammatory injury following myocardial ischemia–reperfusion in the mouse S Toldo, C Marchetti, AG Mauro, J Chojnacki, E Mezzaroma, S Carbone, ... International Journal of Cardiology 209, 215-220, 2016 | 200 | 2016 |
| Interleukin‐1 blockade inhibits the acute inflammatory response in patients with ST‐segment–elevation myocardial infarction A Abbate, CR Trankle, LF Buckley, MJ Lipinski, D Appleton, D Kadariya, ... Journal of the American Heart Association 9 (5), e014941, 2020 | 194 | 2020 |
| Effects of sodium‐glucose cotransporter 2 inhibitors on 24‐hour ambulatory blood pressure: a systematic review and meta‐analysis WL Baker, LF Buckley, MS Kelly, JD Bucheit, ED Parod, R Brown, ... Journal of the American Heart Association 6 (5), e005686, 2017 | 188 | 2017 |
| Interleukin-1 Blockade in Recently Decompensated Systolic Heart Failure: Results From REDHART (Recently Decompensated Heart Failure Anakinra Response Trial) BW Van Tassell, JM Canada, S Carbone, C Trankle, L Buckley, CO Erdle, ... Circulation: Heart Failure 10 (11), e004373, 2017 | 186 | 2017 |
| A review of obesity, physical activity, and cardiovascular disease A Elagizi, S Kachur, S Carbone, CJ Lavie, SN Blair Current obesity reports 9, 571-581, 2020 | 181 | 2020 |
| Comparative safety of interleukin-1 blockade with anakinra in patients with ST-segment elevation acute myocardial infarction (from the VCU-ART and VCU-ART2 pilot studies) A Abbate, MC Kontos, NA Abouzaki, RD Melchior, C Thomas, ... The American journal of cardiology 115 (3), 288-292, 2015 | 168 | 2015 |
| Pharmacologic inhibition of the NLRP3 inflammasome preserves cardiac function after ischemic and nonischemic injury in the mouse C Marchetti, S Toldo, J Chojnacki, E Mezzaroma, K Liu, FN Salloum, ... Journal of cardiovascular pharmacology 66 (1), 1-8, 2015 | 163 | 2015 |
| Interleukin-18 as a therapeutic target in acute myocardial infarction and heart failure LC O’Brien, E Mezzaroma, BW Van Tassell, C Marchetti, S Carbone, ... Molecular Medicine 20 (1), 221-229, 2014 | 162 | 2014 |
| Il-1 blockade in patients with heart failure with preserved ejection fraction: Results from dhart2 BW Van Tassell, CR Trankle, JM Canada, S Carbone, L Buckley, ... Circulation: Heart Failure 11 (8), e005036, 2018 | 152 | 2018 |
| Lean mass abnormalities in heart failure: the role of sarcopenia, sarcopenic obesity, and cachexia S Carbone, HE Billingsley, P Rodriguez-Miguelez, DL Kirkman, R Garten, ... Current problems in cardiology 45 (11), 100417, 2020 | 139 | 2020 |
| Interleukin-1 blockade in acute decompensated heart failure: a randomized, double-blinded, placebo-controlled pilot study BW Van Tassell, NA Abouzaki, CO Erdle, S Carbone, CR Trankle, ... Journal of cardiovascular pharmacology 67 (6), 544-551, 2016 | 126 | 2016 |
| Interleukin‐1 blockade in heart failure with preserved ejection fraction: rationale and design of the Diastolic Heart Failure Anakinra Response Trial 2 (D‐HART2) BW Van Tassell, LF Buckley, S Carbone, CR Trankle, JM Canada, ... Clinical cardiology 40 (9), 626-632, 2017 | 120* | 2017 |
Antonio AbbateProfessor of Cardiology, University of Virginia在 virginia.edu 的电子邮件经过验证
